Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Bvld 99, DK-8200 Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Bvld. 99, DK-8200 Aarhus, Denmark.
Europace. 2024 Feb 1;26(2). doi: 10.1093/europace/euae031.
Cardiac electrophysiology is an evolving field that relies heavily on costly device- and catheter-based technologies. An increasing number of patients with heart rhythm disorders are becoming eligible for cardiac interventions, not least due to the rising prevalence of atrial fibrillation and increased longevity in the population. Meanwhile, the expansive costs of healthcare face finite societal resources, and a cost-conscious approach to new technologies is critical. Cost-effectiveness analyses support rational decision-making in healthcare by evaluating the ratio of healthcare costs to health benefits for competing therapies. They may, however, be subject to significant uncertainty and bias. This paper aims to introduce the basic concepts, framework, and limitations of cost-effectiveness analyses to clinicians including recent examples from clinical electrophysiology and device therapy.
心脏电生理学是一个不断发展的领域，严重依赖昂贵的设备和基于导管的技术。越来越多的心律紊乱患者有资格接受心脏介入治疗，这主要是由于房颤的发病率上升和人口寿命延长。与此同时，医疗保健的高昂成本面临着有限的社会资源，因此对新技术采取具有成本意识的方法至关重要。成本效益分析通过评估竞争疗法的医疗成本与健康效益的比率，为医疗保健中的合理决策提供支持。然而，它们可能会受到重大不确定性和偏差的影响。本文旨在向临床医生介绍成本效益分析的基本概念、框架和局限性，包括来自临床电生理学和器械治疗的最新实例。
